Relmada Therapeutics Inc (NASDAQ:RLMD) currently has a daily average trading volume of 1.79M but it saw 1282193 shares traded in last market. With a market cap of 22.34M USD, the company’s current market price of $0.67 came rising about 25.53 while comparing to the previous closing price of $0.54. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.47 and as low as $0.24.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Mizuho which downgraded the stock as “Neutral” in its note to investors issued on December 05, 2024, recommending a price target of between $23 and $1 for it. Jefferies upgraded its recommendation for the stock as a “Buy” from “Hold” on September 17, 2024 while assigning a price target range of $3.50-$13. Goldman also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $3 and $2.
Over the week, RLMD’s stock price is moving -3.83% down while it is 1.68% when we observe its performance for the past one month. Year-to-date it is -77.56% down and over the past year, the stock is showing an upside performance of 29.44%.
Currently, Relmada Therapeutics Inc’s total number of outstanding shares is 33.19M. Company’s return on investment (ROI) stands at -337.38% and return on equity (ROE) at -160.26%. Stock’s beta reads 0.62. Stock has a price to book (P/B) ratio of 1.00. Its return on asset (ROA) is -135.09% on average.
